Conditions: Neoplasms
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 7
Healthy volunteers: no

Brief summary:
Investigation of absorption, distribution, metabolism and excretion (ADME) and assessment of safety, tolerability and preliminary therapeutic effects of \[14C\]volasertib in patients with advanced solid tumours.

Detailed description:

Arms:
arm 1: BI 6727 cycles in every 21 days

Interventions: intervention 1: BI 6727
Intervention descriptions: intervention 1: PLK-1 inhibitor

Protocol document: